Potomac, Maryland
United States
27
2025-09-30
The entities that hold a legal rights for patent applications filed by inventor Deisseroth Albert B.:
Albert B. Deisseroth from Potomac, US has applied for patents for these inventions. The list has both pending applications and granted patents:
SARS-CoV-2 fusion protein vaccine/regimen
#2 | 2024-06-13COMBINATION CANCER THERAPY
#3 | 2023-08-03mRNA VACCINE DESIGN USING MULTIPLE INTERACTING IMMUNO-STIMULATORY PATHWAYS, FOR CANCER AND INFECTIOUS DISEASES
#4 | 2022-05-12CD40 LIGAND FUSION PROTEIN VACCINE
#5 | 2021-10-26Burkholderia pseudomallei composition
#6 | 2020-02-13Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
#7 | 2019-10-01Dengue hemorrhagic fever virus vaccine
#8 | 2019-05-21Pharmaceutical compositions and methods of blocking
#9 | 2019-03-07Combination cancer therapy
#10 | 2019-01-22TAA/CD4OL composition/vaccine for malaria
#11 | 2019-01-08Multivalent DNA composition for
#12 | 2019-01-01Vaccines for herpes simplex virus 1 and 2
#13 | 2018-12-11Composition and method against C-difficile
#14 | 2018-11-20TAA/ecdCD40L oncolytic virus
#15 | 2018-02-13Ebola virus composition/vaccine
#16 | 2017-08-24Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
#17 | 2017-06-29CD40 ligand fusion protein vaccine
#18 | 2017-06-29Methods and compositions for suppressing virulence of methicillin resistant
#19 | 2017-05-09TAA/CD40L vaccine for malaria
#20 | 2017-03-09Adenoviral vector vaccine
#21 | 2016-12-27Methods and compositions for suppressing virulence of methicillin resistant
#22 | 2015-03-05Methods for generating immunity to antigen
#23 | 2014-05-08TULAREMIA-TAA/CD40L VACCINE
#24 | 2014-03-20Adenoviral expression vector encoding a CD40L fusion protein
#25 | 2013-06-13PHARMACEUTICAL COMPOSITIONS AND METHODS OF BLOCKING BACILLUS ANTHRACIS
#26 | 2012-11-01Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein
#27 | 2012-08-02Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
285690 ⎘